About

2019 New Frontiers in 3D

Forging New Frontiers in 3D for Human Health

Toward Greater Human Physiological Relevance

There is growing interest in scalable 3D in vitro technologies and organ-on-a-chip systems that is causing a paradigm shift in how we approach drug discovery and development. But how do you separate the hype from practical innovations that are proven, tested and ready to implement for industry applications? The New Frontiers in 3D conference offers an international forum for you to meet with other leaders and innovators in the field of pharmaceutical drug discovery for discussing challenges and opportunities to advance preclinical research, with an emphasis on translational approaches, challenges, and successes.

This one-day symposium will include sessions on advanced 3D platforms for drug safety and efficacy testing, as well practical guidance for implementing the latest organ-on-a chip microfluidic systems. Keynote and invited speakers from industry and academic institutes will share their experiences and perspectives. Join the discussion and help shape the future of preclinical drug testing.

Who Should Attend

  • Pharma and biotech research scientists involved in drug discovery
  • Toxicologists engaged in drug safety testing
  • Research and innovation management.
  • Representatives from regulatory agencies
Past Conferences

Join us at the MIT Sanberg Center to explore the latest advances modeling human physiology

Sponsorship opportunities

Advancing human model systems for drug discovery

The New Frontiers in 3D conference organizers seek to provide an educational and exploratory forum on the latest advances in 3D cell culture technology for preclinical testing. We strive to provide a forum for leaders and researchers who are actively engaged in working with in vitro models and testing platforms to discuss how we can harness emerging technology to better predict human in vivo responses to drugs and treatments earlier. If you have capabilities or technologies that would benefit our audience, this meeting provides a unique platform to showcase your solutions, network with participants, and source opportunities for partnerships.  For more details about what’s included in our sponsorship package, apply to reserve your spot before March 1, 2019.

Apply

Past Conferences

Johns Hopkins University, Baltimore, MD USA October 13, 2016

The 2016 New Frontiers in 3D conference focused on 3D cell culture-based screening technologies and was organized by InSphero AG, National Center for Advancing Translational Sciences (NCATS), Centers for Alternatives to Animal Testing (CAAT), and Promega Corp. This inaugural event brought together more than 100 international experts in the translational application of advanced 3D model systems to drug discovery, safety testing, and beyond. The aim of the scientific advisory board was to foster discussion among speakers and attendees with diverse regulatory, industry, and academic perspectives of 3D models and screening technologies.  Speakers included:

  • Drug Discovery Track
    • Michael Gottesman, MD, Center for Cancer Research, NCI, NIH
    • Lesley A. Mathews Griner, PhD, Novartis Institutes for
      Biomedical Research
    • Robert Vries, PhD, Hubrecht Organoid Technology (HUB)
    • Madhu Lal-Nag, PhD, NCATS
    • Arno Amann, PhD, Medical University Innsbruck
    • Nikolaos Tsamandouras, PhD, MIT
  • Toxicology and Safety Testing Track
    • Thomas Hartung, MD, PhD, Johns Hopkins University Bloomberg School of Public Health
    • Philip Hewitt, PhD, Merck KGaA
    • Stephen S. Ferguson, PhD, National Institute of Environmental Health Sciences (NIEHS)
    • Olga Gordeeva, PhD, Russian Academy of Sciences
    • Jose A. Lebron, PhD, Merck
    • Piyush Bajaj, PhD, Pfizer